BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 92
+0.02
+2.2222%
$
- Market Cap
- P/E Ratio
- Div Yield
10,052 Volume
-1.39 Eps
$ 0.9
Previous Close Investors:
Want to track BCTXL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.2
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding -
Float 6.41M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.23K
Average volume (90 days) 33.53K
Price summary
52-Week low 0.61
52-Week high 1.4
Beta 1.63
50-Day moving average -
200-Day moving average -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.89%
Return on equity -1.79%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -30.63M
Net income to common (ttm) -29.64M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 29.9M
Total cash per share (mrq) 4.12
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 10.1%
Book value per share (mrq) 4.26
Cash Flow
Cash flow statement -30.97M
Levered free cash flow (LFCF) -20.49M
